0001567619-21-016019.txt : 20210818 0001567619-21-016019.hdr.sgml : 20210818 20210818065907 ACCESSION NUMBER: 0001567619-21-016019 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210812 FILED AS OF DATE: 20210818 DATE AS OF CHANGE: 20210818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Helsel Dave CENTRAL INDEX KEY: 0001543753 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 211184983 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 4/A 1 doc1.xml FORM 4/A X0306 4/A 2021-08-12 2021-08-17 0 0001275187 ANGIODYNAMICS INC ANGO 0001543753 Helsel Dave 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 SVP Global Operations and R&D Common Stock 2021-08-12 4 M 0 11406 0 A 33228 D Common Stock 2021-08-12 4 F 0 3347 27.29 D 29881 D Performance Right 2021-08-12 4 M 0 9834 0 D Common Stock 9834 0 D On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold. This acquisition of 11,406 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018. The exempt disposition of 3,347 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018. On July 18, 2018, the reporting person received a target grant of 9,834 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 11,406 shares of Common Stock were issued to the reporting person under this grant. /s/ Richard C. Rosenzweig, Attorney in Fact 2021-08-17